Home> Regulatory Information

MoyoAssist® Extracorporeal Ventricular Assist Device and Extracorporeal Ventricular Assist Pump Head and Circuit Approved for Marketing

CCFDIE|Updated: 2024-04-28

     

Recently, the innovative products MoyoAssist® Extracorporeal Ventricular Assist Device and Extracorporeal Ventricular Assist Pump Head and Circuit of magAssist Inc. (Suzhou) were approved for marketing.

The MoyoAssist® Extracorporeal Ventricular Assist Device consists of maglev motor, console and accessories. The Extracorporeal Ventricular Assist Pump Head and Circuit consists of centrifugal pump head, side-hole straight joint, luer taper, circuit clamp, and cable tie. The two products are used in combination, connected to blood vessels to form a bypass branch. The pump head blade is driven to rotate by console and maglev motor, to provide kinetic energy for the blood pressurization, used for cardiac postoperative patients temporary extracorporeal mechanical circulation assistance.

The product adopts full magnetic levitation blood pump technology with anti-vibration and anti-twisting properties as well as better blood flow field design, which can effectively reduce the average incidence of blood compatibility-related complications.

The NMPA will strengthen the post-marketing surveillance of the product to protect the safety of medical devices used by patients.